ASCO Schedule

NewYork-Presbyterian at ASCO 2016

Friday, June 3

1:00-1:20 PM

"American Board of Internal Medicine 2015 Update"

Presented by:
Joseph T. Ruggiero, MD | NewYork-Presbyterian & Weill Cornell Medicine

1:20-1:40 PM

Working With a Biostatistician

Presented by:
Karla V. Ballman | NewYork-Presbyterian & Weill Cornell Medicine

3:00-3:20 PM

Small Group Discussion Table Leader

Presented by:
Dawn Hershman, MD | NewYork-Presbyterian & Columbia University Medical Center

3:40-4:00 PM

Small Group Discussion Table Leader

Presented by:
Gary Schwartz, MD | NewYork-Presbyterian & Columbia University Medical Center

Saturday, June 4

8:00-8:15 AM

"Translating Genomics Into the Clinic"

Presented by:
Himisha Beltran, MD | NewYork-Presbyterian & Weill Cornell Medicine

8:00-11:30 AM

Multimodality therapy in IIIA-N2 NSCLC: Factors associated with treatment selection and survival

Presented by:
Andrew Brandmaier, MD | NewYork-Presbyterian & Weill Cornell Medicine

8:40-9:00 AM

Using Technology to Improve Quality and Safety

Presented by:
Melissa Accordino, MD | NewYork-Presbyterian & Columbia University Medical Center

1:00-4:30 PM

Chemotherapy, acute health care events, and hospice use among stage IV pancreatic cancer patients

Presented by:
Yuhua Bao, PhD | NewYork-Presbyterian & Weill Cornell Medicine

1:00-4:30 PM

The messenger matters: Relative influence of oncologists versus other care team members on advanced cancer patients’ illness understanding

Presented by:
Simon Mentis Cohen | NewYork-Presbyterian & Weill Cornell Medicine

1:15-2:30 PM

Point: Adult Approach to Adolescent and Young Adult Hodgkin Lymphoma

Presented by:
John Leonard, MD | NewYork-Presbyterian & Weill Cornell Medicine

1:15-2:30 PM

Locally Advanced Esophageal and Gastric Cancers: When Neoadjuvant Therapy Fails

Presented by:
Manish Shah, MD | NewYork-Presbyterian & Weill Cornell Medicine

2:09-2:21 PM

Immunotherapy in Rare Thoracic Malignancies

Presented by:
Naiyer Rizvi, MD | NewYork-Presbyterian & Columbia University Medical Center

1:35-1:55 PM

Medication Compliance and Out of Pocket Costs

Presented by:
Dawn Hershman, MD | NewYork-Presbyterian & Columbia University Medical Center

Sunday, June 5

8:00-11:00 AM

The changing utilization of neoadjuvant chemotherapy among different racial groups and its effect on mastectomy rates

Presented by:
Tiffany Pinchinat, MD | NewYork-Presbyterian & Weill Cornell Medicine

8:00-11:30 AM

A phase 1 study of enoblituzumab in combination with pembrolizumab in patients with advanced B7-H3-expressing cancers

Presented by:
Naiyer Rizvi, MD | NewYork-Presbyterian & Columbia University Medical Center

8:12-8:24 AM

Comorbidities and risk of chemotherapy-induced peripheral neuropathy among participants in SWOG clinical trials

Presented by:
Dawn Hershman, MD | NewYork-Presbyterian & Columbia University Medical Center

8:24-8:36 AM

Body mass index, lifestyle factors, and taxane-induced neuropathy in women with breast cancer: The Pathways Study

Presented by:
Heather Greenlee, MD | NewYork-Presbyterian & Columbia University Medical Center

8:30-8:50 AM

Hematologic Malignancies—Leukemia, Myelodysplastic Syndromes, and Allotransplant

Presented by:
Joseph Jurcic, MD | NewYork-Presbyterian & Columbia University Medical Center

9:24-9:36 AM

Just what are spiritual needs of cancer patients? An empirical study in a diverse population

Presented by:
Alan Astrow, MD (Methodist) | NewYork-Presbyterian & Weill Cornell Medicine

9:36-9:48 AM

Tyrosine Kinase Inhibitors in Non-Gist Sarcomas: Are We Making Progress?

Presented by:
Gary Schwartz, MD | NewYork-Presbyterian & Columbia University Medical Center

9:45 AM-12:45 PM

A phase 2 trial of ABVD followed by brentuximab vedotin consolidation in limited stage non-bulky Hodgkin lymphoma

Kristy Richards, MD | NewYork-Presbyterian & Weill Cornell Medicine

Monday, June 6

8:00-11:30 AM

Evaluating genetic and genomic sequencing knowledge from parents and young adult cancer survivors

Presented by:
Trisha Ali-Shaw, MS | NewYork-Presbyterian & Columbia University Medical Center

8:00-11:30 AM

Risk of arterial thromboembolism in patients with colorectal cancer

Presented by:
Babak B. Navi, MD, MS | NewYork-Presbyterian & Weill Cornell Medicine

8:00-11:30 AM

A first in human experience of the anti-CD37 antibody-drug conjugate AGS67E in lymphoid malignancies

Presented by:
Ahmed Sawas, MD | NewYork-Presbyterian & Columbia University Medical Center

1:00-4:30 PM

Accuracy of oncologists’ life-expectancy estimates provided to their advanced cancer patients: Correlates and outcomes

Presented by:
Jason P Lambden, MSPH | NewYork-Presbyterian & Weill Cornell Medicine

1:00-4:30 PM

Natural history of clinical complete response to neoadjuvant chemotherapy for urothelial carcinoma of the bladder: Updated single-institution experience

Presented by:
Justin T. Matulay, MD | NewYork-Presbyterian & Columbia University Medical Center

1:15-1:27 PM

Role of Antiangiogenic Therapies in Pediatric Solid Tumors

Presented by:
Julia Lynne Glade Bender, MD | NewYork-Presbyterian & Columbia University Medical Center

1:15-1:27 PM

PI3 Kinase Inhibition in Chronic Lymphocytic Leukemia

Presented by:
Nicole Lamanna, MD | NewYork-Presbyterian & Columbia University Medical Center

3:00-4:30 PM

Radiomics, Immunotherapy, and Value in Glioma

Presented by:
Fabio Massaiti Iwamoto, MD | NewYork-Presbyterian & Columbia University Medical Center

4:45-6:00 PM

Patient and Survivor Care

Presented by:
Tessa Cigler, MD | NewYork-Presbyterian & Weill Cornell Medicine

5:05-5:25 PM

What Is the Minimal Trial Design for Drug Approval in Rare Cancers?

Presented by:
Tito Fojo, MD, PhD | NewYork-Presbyterian & Columbia University Medical Center

Tuesday, June 7